Medicines Control Authority of Zimbabwe

02/12/2025

Substandard and falsified (SF) medicines threaten millions of people worldwide.
Report to the MCAZ, any suspected SF products you may encounter. The Authority urges the public to access registered medicines from licenced persons and premises.

01/12/2025

Today, the Authority joins the global community in commemorating Day 2025.
MCAZ reaffirm its commitment to protecting public health by ensuring access to safe, effective, and good-quality medicines and medical devices.

Last month, the Authority approved and registered , an innovative long-acting medicine for pre-exposure prophylaxis (PrEP) to help prevent HIV-1 infection—supporting national and global efforts in the fight against HIV and AIDS.

Together, we can strengthen the response, save lives, and build a healthier future.

24/11/2025

🚨 ANNOUNCEMENT

🔊 The Medicines Control Authority of Zimbabwe (MCAZ) announces the expedited approval of , an innovative long-acting medicine for pre-exposure prophylaxis (PrEP) to prevent HIV-1 infection.

The application, submitted by Gilead on the 29th of October 2025, underwent a rigorous evaluation and was finalised in twenty-three (23) days, demonstrating the Authority’s commitment to ensuring timely access to essential, life-saving health products.

The registration of marks a significant advancement in Zimbabwe’s HIV prevention strategy. By providing a long-acting alternative to daily oral , this product has the potential to improve adherence and expand prevention options for populations most vulnerable to HIV infection.

🔴 Details:https://portal.mcaz.co.zw/wp-content/uploads/2025/11/MEDIA-RELEASE-MCAZ-Registers-LENACAPAVIR_RvdDK-1ZAM.pdf

20/11/2025

MCAZ at the Zimbabwe Antimicrobial Resistance (AMR) Conference 2025
19–20 November | HICC

Quality-assured medicines are essential in protecting public health and preventing the spread of antimicrobial resistance (AMR).

At this year’s conference, MCAZ showcased its (handheld) portable field detection technologies that help rapidly identify substandard and falsified medicines in both human and veterinary sectors. These innovations strengthen surveillance beyond the laboratory and support timely regulatory action.

The Authority also had the opportunity to demonstrate the devices to the Minister of Ministry of Health and Child Care, highlighting the importance of technology and innovation in the fight against antimicrobial resistance.

Poor-quality medicines fuel AMR. Through strong surveillance and a One Health approach, MCAZ continues to protect people, animals, and the environment.

20/11/2025

20/11/2025

Scenes from the MCAZ 2026-2030 Strategic Planning Workshop.


fans

19/11/2025

19/11/2025

MCAZ is hosting its 2026–2030 Strategic Planning Workshop, aligned with Zimbabwe’s national development priorities.

Present are MCAZ Board Members and Management, together with officials from the Ministry of Health, Ministry of Finance, Corporate Governance Unit (OPC), and the Public Service Academy.

A strong, collaborative start to shaping the future of Zimbabwe’s medicines regulation

17/11/2025

🔊 The Medicines Control Authority of Zimbabwe (MCAZ) is pleased to inform all stakeholders of a significant continental milestone in regulatory cooperation—the operationalisation of the ML3 NRAs Reliance Mechanism. This initiative was launched in collaboration with AUDA-NEPAD and eight other WHO Maturity Level 3 (ML3) National Regulatory Authorities (NRAs) across Africa.

🔴 Details:https://portal.mcaz.co.zw/wp-content/uploads/2025/11/Circular-32-of-2025_Operationalisation-of-the-ML3-NRAs-reliance-mechanism-.pdf

09/11/2025

That’s a wrap on this year’s campaign! 🎉

Thanks for following our channels this week as we highlighted the importance of reporting side effects to https://vigiflow-eforms.who-umc.org/zw/adr and how we all have the power to make medicines safer.

But the work doesn’t stop here – MCAZ will continue to collect and monitor reports of suspected side effects from patients and healthcare professionals to ensure medicines are used safely.

Remember that every report counts when it comes to the safety of medicines and patients worldwide.

Continue to and help us make medicines safer ✅

08/11/2025

Doctors, pharmacists, and nurses dedicate their lives to the safety of patients. Here are 4 ways that healthcare professionals can continue to be and help us strengthen pharmacovigilance systems globally:

✔️ Inform your patients of the potential side effects of medicines
✔️ Show your patients how and where to report suspected side effects
✔️ Remind patients to read the patient information leaflet and follow dosage instructions
✔️ Report suspected side effects to [reporting system]


Help us make medicines safer for all by raising awareness of pharmacovigilance and the importance of reporting side effects. Learn more 👉 https://vigiflow-eforms.who-umc.org/zw/adr

08/11/2025

How can you be a ?

Every patient or patient carer has the power to make medicines safer for all. Here are 4 ways that you can be more vigilant in the use of medicines and help raise awareness of :

✔️ Talk to your healthcare professional about the potential side effects of a medicine
✔️ Ask your healthcare professional how and where you can report suspected side effects
✔️ Read the patient information leaflet supplied with the medicine and follow the dosage instructions
✔️ Tell your healthcare professional about suspected side effects and report them to [reporting system]

Every report submitted to https://vigiflow-eforms.who-umc.org/zw/adr counts when it comes to the safety of medicines and patients worldwide.

Join the cause – 👉 https://primaryreporting.who-umc.org/ZW